Buffett just messed things up for Teva short-sellers
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
IT'S not like there was any real risk in shorting an easy target like Teva Pharmaceutical Industries. Warren Buffett could come along to destroy your bet, but what were the odds of that happening?
Oops.
It's not a happy Valentine's Day for Teva short-sellers. After the market closed Wednesday, a filing from Buffett's Berkshire Hathaway disclosed that it made only one new investment during the latest quarter. Unluckily for Teva bears, it was the Israeli generic-drug maker they've been betting against to the tune of US$1.2 billion.
Share with us your feedback on BT's products and services
TRENDING NOW
Ministry of Home Affairs Permanent Secretary Pang Kin Keong to retire
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
